HCV Protease Inhibitors
HCV (Hepatitis C virus) protease inhibitors are a class of antiviral drugs that specifically target the NS3/4A protease enzyme of the Hepatitis C virus. This enzyme plays a crucial role in viral replication by cleaving viral polyproteins into functional components essential for viral maturation. By inhibiting the NS3/4A protease, these inhibitors prevent the virus from replicating and producing infectious viral particles. HCV protease inhibitors are typically used in combination with other antiviral agents to achieve potent and sustained suppression of viral replication, thereby improving treatment outcomes for Hepatitis C patients.
